Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

CompletedOBSERVATIONAL
Enrollment

607

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Irritable Bowel Syndrome
Trial Locations (24)

49000

Site reference ID/Investigaot# 94525, Guadalajara

54055

Site refernce ID/Investigator# 94527, Mexico City

89190

Site reference ID/Investigator# 94523, Tampico

100034

Site reference ID/Investigator# 94519, Beijing

200127

Site reference ID/Investigator # 94518, Shanghai

200433

Site reference ID/Investigator # 94517, Shanghai

430022

Site reference ID/Investigator # 94515, Wuhan

510080

Site reference ID/Investigator# 94521, Guangzhou

510515

Site reference ID/Investigator# 95475, Guangzhou

Unknown

Site reference ID/Investigator # 94516, Shanghai

Site Reference ID/Investigator# 95908, Alexandria

Site reference ID/Investigator# 95900, Cairo

Site reference ID/Investigator# 95901, El Sharkya

Site reference ID/Investigator# 95902, Giza

Site reference ID/Investigator# 95903, Giza

Site Reference ID/Investigator# 95906, Port Said

15-270

Site reference ID/Investigator# 85314, Bialystok

15-351

Site Reference ID/Investigator# 85297, Bialystok

85-079

Site Reference ID/Investigator# 85298, Bydgoszcz

40-031

Site Reference ID/Investigator# 85293, Katowice

91-473

Site Reference ID/Investigator# 85296, Lodz

10-501

Site reference ID/Investigator# 85313, Olsztyn

60-193

Site Reference ID/Investigator# 85295, Poznan

60-539

Site Reference ID/Investigator# 85294, Poznan

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

CHILTERN International GmbH

UNKNOWN

lead

Abbott

INDUSTRY